The fears over mRNA-vaccine grant cancellations come after NIH staff members were instructed to compile a list of grants for ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Yet today, at what should be a celebration of this revolutionary technology’s potential, we find ourselves wondering about the future of mRNA research. The scientific community is watching if funding ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

This study shows that RNA decay rather than the presence of premature termination codons triggers a TA-like response.

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...